McPhy Energy Valuation
Is 0QTF undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0QTF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 0QTF's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 0QTF's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0QTF?
Key metric: As 0QTF is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 0QTF's PS Ratio? | |
|---|---|
| PS Ratio | 1.3x |
| Sales | €21.25m |
| Market Cap | €28.66m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.2x |
| Enterprise Value/EBITDA | -0.09x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0QTF's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 4.1x | ||
TAND Tan Delta Systems | 15.2x | 81.7% | UK£17.6m |
HMSG HMS Hydraulic Machines & Systems Group | 0.08x | 4.0% | US$81.1m |
MCON Mincon Group | 0.7x | 6.7% | UK£80.7m |
RNO Renold | 0.4x | 5.5% | UK£98.1m |
0QTF McPhy Energy | 1.3x | 81.5% | €28.7m |
Price-To-Sales vs Peers: 0QTF is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (5.4x).
Price to Sales Ratio vs Industry
How does 0QTF's PS Ratio compare vs other companies in the GB Machinery Industry?
Price-To-Sales vs Industry: 0QTF is good value based on its Price-To-Sales Ratio (1.3x) compared to the UK Machinery industry average (1.7x).
Price to Sales Ratio vs Fair Ratio
What is 0QTF's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.3x |
| Fair PS Ratio | 2.3x |
Price-To-Sales vs Fair Ratio: 0QTF is good value based on its Price-To-Sales Ratio (1.3x) compared to the estimated Fair Price-To-Sales Ratio (2.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €1.00 | €2.45 +145.1% | 37.9% | €4.00 | €1.50 | n/a | 5 |
| Nov ’25 | €1.68 | €2.45 +45.6% | 37.9% | €4.00 | €1.50 | n/a | 5 |
| Oct ’25 | €2.07 | €3.55 +71.3% | 30.2% | €5.00 | €1.90 | n/a | 5 |
| Sep ’25 | €2.11 | €3.62 +71.4% | 28.6% | €5.00 | €1.90 | n/a | 5 |
| Aug ’25 | €2.53 | €3.62 +42.9% | 28.6% | €5.00 | €1.90 | n/a | 5 |
| Jul ’25 | €2.38 | €3.81 +59.9% | 27.5% | €5.00 | €1.90 | n/a | 6 |
| Jun ’25 | €3.12 | €3.81 +22.0% | 27.5% | €5.00 | €1.90 | n/a | 6 |
| May ’25 | €2.10 | €3.50 +67.1% | 35.3% | €5.00 | €1.60 | n/a | 7 |
| Apr ’25 | €1.89 | €3.50 +84.9% | 35.3% | €5.00 | €1.60 | n/a | 7 |
| Mar ’25 | €2.04 | €3.74 +83.1% | 24.7% | €5.00 | €2.45 | n/a | 7 |
| Feb ’25 | €2.77 | €4.26 +53.6% | 26.3% | €6.50 | €2.61 | n/a | 7 |
| Jan ’25 | €3.37 | €5.97 +77.4% | 71.0% | €16.00 | €2.61 | n/a | 7 |
| Dec ’24 | €3.71 | €7.72 +108.0% | 54.2% | €16.00 | €4.00 | n/a | 6 |
| Nov ’24 | €3.65 | €9.97 +172.9% | 51.1% | €17.00 | €4.00 | €1.68 | 7 |
| Oct ’24 | €5.13 | €13.82 +169.1% | 52.0% | €30.00 | €5.00 | €2.07 | 8 |
| Sep ’24 | €6.48 | €14.13 +117.9% | 48.4% | €30.00 | €7.50 | €2.11 | 8 |
| Aug ’24 | €7.67 | €14.88 +93.9% | 45.8% | €30.00 | €7.52 | €2.53 | 8 |
| Jul ’24 | €8.22 | €15.19 +84.9% | 43.2% | €30.00 | €7.52 | €2.38 | 8 |
| Jun ’24 | €9.48 | €15.93 +68.1% | 37.5% | €30.00 | €10.00 | €3.12 | 8 |
| May ’24 | €12.28 | €16.56 +34.9% | 34.1% | €30.00 | €11.00 | €2.10 | 8 |
| Apr ’24 | €12.89 | €16.56 +28.5% | 34.1% | €30.00 | €11.00 | €1.89 | 8 |
| Mar ’24 | €13.22 | €16.30 +23.3% | 34.6% | €30.00 | €11.00 | €2.04 | 8 |
| Feb ’24 | €13.98 | €16.54 +18.3% | 33.6% | €30.00 | €11.00 | €2.77 | 8 |
| Jan ’24 | €12.39 | €16.59 +33.8% | 33.0% | €30.00 | €12.00 | €3.37 | 8 |
| Dec ’23 | €14.06 | €16.59 +18.0% | 33.0% | €30.00 | €12.00 | €3.71 | 8 |
| Nov ’23 | €11.39 | €16.41 +44.1% | 34.2% | €30.00 | €11.40 | €3.65 | 8 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Babcock International Group
UK£2.6b
Engages in the design, development, manufacture, and integration of specialist systems for aerospace, defense, and security in the United Kingdom, rest of Europe, Africa, North America, Australasia, and internationally.
BABL
UK£5.16
7D
-1.0%
1Y
30.5%
Aalberts
€3.8b
Offers mission-critical technologies for aerospace, automotive, building, and maritime sectors.
0NX1
€34.35
7D
0.9%
1Y
-5.6%
Renold
UK£97.5m
Engages in the manufacture and sale of high precision engineered products and solutions in the United Kingdom, rest of Europe, the United States, Canada, Australasia, China, India, and internationally.
RNO
UK£0.49
7D
6.1%
1Y
48.0%